Semiconductor real-time quality assurance dosimetry in brachytherapy

Mauro Carrara, Dean Cutajar, Saree Alnaghy, Anthony Espinoza, Anna Romanyukha, Stefano Presilla, Chiara Tenconi, Annamaria Cerrotta, Carlo Fallai, Mitra Safavi-Naeini, Marco Petasecca, Alannah Kejda, Michael Lerch, Stéphanie Corde, Michael Jackson, Andrew Howie, Joseph Bucci, Anatoly B Rosenfeld

Research output: Contribution to journalArticle

Abstract

With the increase in complexity of brachytherapy treatments, there has been a demand for the development of sophisticated devices for delivery verification. The Centre for Medical Radiation Physics (CMRP), University of Wollongong, has demonstrated the applicability of semiconductor devices to provide cost-effective real-time quality assurance for a wide range of brachytherapy treatment modalities. Semiconductor devices have shown great promise to the future of pretreatment and in vivo quality assurance in a wide range of brachytherapy treatments, from high-dose-rate (HDR) prostate procedures to eye plaque treatments. The aim of this article is to give an insight into several semiconductor-based dosimetry instruments developed by the CMRP. Applications of these instruments are provided for breast and rectal wall in vivo dosimetry in HDR brachytherapy, urethral in vivo dosimetry in prostate low-dose-rate (LDR) brachytherapy, quality assurance of HDR brachytherapy afterloaders, HDR pretreatment plan verification, and real-time verification of LDR and HDR source dwell positions.

Original languageEnglish
Pages (from-to)133-145
Number of pages13
JournalBrachytherapy
Volume17
Issue number1
DOIs
Publication statusPublished - 2018

Fingerprint

Semiconductors
Brachytherapy
Physics
Equipment and Supplies
Prostate
Radiation
Therapeutics
Breast
Costs and Cost Analysis

Keywords

  • Brachytherapy/standards
  • Breast
  • Breast Neoplasms/radiotherapy
  • Female
  • Humans
  • In Vivo Dosimetry/methods
  • Male
  • Organs at Risk
  • Prostatic Neoplasms/radiotherapy
  • Quality Assurance, Health Care/methods
  • Radiation Dosage
  • Radiation Dosimeters
  • Radiotherapy Dosage
  • Rectum
  • Semiconductors
  • Urethra

Cite this

Carrara, M., Cutajar, D., Alnaghy, S., Espinoza, A., Romanyukha, A., Presilla, S., ... Rosenfeld, A. B. (2018). Semiconductor real-time quality assurance dosimetry in brachytherapy. Brachytherapy, 17(1), 133-145. https://doi.org/10.1016/j.brachy.2017.08.013

Semiconductor real-time quality assurance dosimetry in brachytherapy. / Carrara, Mauro; Cutajar, Dean; Alnaghy, Saree; Espinoza, Anthony; Romanyukha, Anna; Presilla, Stefano; Tenconi, Chiara; Cerrotta, Annamaria; Fallai, Carlo; Safavi-Naeini, Mitra; Petasecca, Marco; Kejda, Alannah; Lerch, Michael; Corde, Stéphanie; Jackson, Michael; Howie, Andrew; Bucci, Joseph; Rosenfeld, Anatoly B.

In: Brachytherapy, Vol. 17, No. 1, 2018, p. 133-145.

Research output: Contribution to journalArticle

Carrara, M, Cutajar, D, Alnaghy, S, Espinoza, A, Romanyukha, A, Presilla, S, Tenconi, C, Cerrotta, A, Fallai, C, Safavi-Naeini, M, Petasecca, M, Kejda, A, Lerch, M, Corde, S, Jackson, M, Howie, A, Bucci, J & Rosenfeld, AB 2018, 'Semiconductor real-time quality assurance dosimetry in brachytherapy', Brachytherapy, vol. 17, no. 1, pp. 133-145. https://doi.org/10.1016/j.brachy.2017.08.013
Carrara M, Cutajar D, Alnaghy S, Espinoza A, Romanyukha A, Presilla S et al. Semiconductor real-time quality assurance dosimetry in brachytherapy. Brachytherapy. 2018;17(1):133-145. https://doi.org/10.1016/j.brachy.2017.08.013
Carrara, Mauro ; Cutajar, Dean ; Alnaghy, Saree ; Espinoza, Anthony ; Romanyukha, Anna ; Presilla, Stefano ; Tenconi, Chiara ; Cerrotta, Annamaria ; Fallai, Carlo ; Safavi-Naeini, Mitra ; Petasecca, Marco ; Kejda, Alannah ; Lerch, Michael ; Corde, Stéphanie ; Jackson, Michael ; Howie, Andrew ; Bucci, Joseph ; Rosenfeld, Anatoly B. / Semiconductor real-time quality assurance dosimetry in brachytherapy. In: Brachytherapy. 2018 ; Vol. 17, No. 1. pp. 133-145.
@article{37dc0750b0844672828b1ddfc9290046,
title = "Semiconductor real-time quality assurance dosimetry in brachytherapy",
abstract = "With the increase in complexity of brachytherapy treatments, there has been a demand for the development of sophisticated devices for delivery verification. The Centre for Medical Radiation Physics (CMRP), University of Wollongong, has demonstrated the applicability of semiconductor devices to provide cost-effective real-time quality assurance for a wide range of brachytherapy treatment modalities. Semiconductor devices have shown great promise to the future of pretreatment and in vivo quality assurance in a wide range of brachytherapy treatments, from high-dose-rate (HDR) prostate procedures to eye plaque treatments. The aim of this article is to give an insight into several semiconductor-based dosimetry instruments developed by the CMRP. Applications of these instruments are provided for breast and rectal wall in vivo dosimetry in HDR brachytherapy, urethral in vivo dosimetry in prostate low-dose-rate (LDR) brachytherapy, quality assurance of HDR brachytherapy afterloaders, HDR pretreatment plan verification, and real-time verification of LDR and HDR source dwell positions.",
keywords = "Brachytherapy/standards, Breast, Breast Neoplasms/radiotherapy, Female, Humans, In Vivo Dosimetry/methods, Male, Organs at Risk, Prostatic Neoplasms/radiotherapy, Quality Assurance, Health Care/methods, Radiation Dosage, Radiation Dosimeters, Radiotherapy Dosage, Rectum, Semiconductors, Urethra",
author = "Mauro Carrara and Dean Cutajar and Saree Alnaghy and Anthony Espinoza and Anna Romanyukha and Stefano Presilla and Chiara Tenconi and Annamaria Cerrotta and Carlo Fallai and Mitra Safavi-Naeini and Marco Petasecca and Alannah Kejda and Michael Lerch and St{\'e}phanie Corde and Michael Jackson and Andrew Howie and Joseph Bucci and Rosenfeld, {Anatoly B}",
note = "Copyright {\circledC} 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.",
year = "2018",
doi = "10.1016/j.brachy.2017.08.013",
language = "English",
volume = "17",
pages = "133--145",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Semiconductor real-time quality assurance dosimetry in brachytherapy

AU - Carrara, Mauro

AU - Cutajar, Dean

AU - Alnaghy, Saree

AU - Espinoza, Anthony

AU - Romanyukha, Anna

AU - Presilla, Stefano

AU - Tenconi, Chiara

AU - Cerrotta, Annamaria

AU - Fallai, Carlo

AU - Safavi-Naeini, Mitra

AU - Petasecca, Marco

AU - Kejda, Alannah

AU - Lerch, Michael

AU - Corde, Stéphanie

AU - Jackson, Michael

AU - Howie, Andrew

AU - Bucci, Joseph

AU - Rosenfeld, Anatoly B

N1 - Copyright © 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

PY - 2018

Y1 - 2018

N2 - With the increase in complexity of brachytherapy treatments, there has been a demand for the development of sophisticated devices for delivery verification. The Centre for Medical Radiation Physics (CMRP), University of Wollongong, has demonstrated the applicability of semiconductor devices to provide cost-effective real-time quality assurance for a wide range of brachytherapy treatment modalities. Semiconductor devices have shown great promise to the future of pretreatment and in vivo quality assurance in a wide range of brachytherapy treatments, from high-dose-rate (HDR) prostate procedures to eye plaque treatments. The aim of this article is to give an insight into several semiconductor-based dosimetry instruments developed by the CMRP. Applications of these instruments are provided for breast and rectal wall in vivo dosimetry in HDR brachytherapy, urethral in vivo dosimetry in prostate low-dose-rate (LDR) brachytherapy, quality assurance of HDR brachytherapy afterloaders, HDR pretreatment plan verification, and real-time verification of LDR and HDR source dwell positions.

AB - With the increase in complexity of brachytherapy treatments, there has been a demand for the development of sophisticated devices for delivery verification. The Centre for Medical Radiation Physics (CMRP), University of Wollongong, has demonstrated the applicability of semiconductor devices to provide cost-effective real-time quality assurance for a wide range of brachytherapy treatment modalities. Semiconductor devices have shown great promise to the future of pretreatment and in vivo quality assurance in a wide range of brachytherapy treatments, from high-dose-rate (HDR) prostate procedures to eye plaque treatments. The aim of this article is to give an insight into several semiconductor-based dosimetry instruments developed by the CMRP. Applications of these instruments are provided for breast and rectal wall in vivo dosimetry in HDR brachytherapy, urethral in vivo dosimetry in prostate low-dose-rate (LDR) brachytherapy, quality assurance of HDR brachytherapy afterloaders, HDR pretreatment plan verification, and real-time verification of LDR and HDR source dwell positions.

KW - Brachytherapy/standards

KW - Breast

KW - Breast Neoplasms/radiotherapy

KW - Female

KW - Humans

KW - In Vivo Dosimetry/methods

KW - Male

KW - Organs at Risk

KW - Prostatic Neoplasms/radiotherapy

KW - Quality Assurance, Health Care/methods

KW - Radiation Dosage

KW - Radiation Dosimeters

KW - Radiotherapy Dosage

KW - Rectum

KW - Semiconductors

KW - Urethra

U2 - 10.1016/j.brachy.2017.08.013

DO - 10.1016/j.brachy.2017.08.013

M3 - Article

VL - 17

SP - 133

EP - 145

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 1

ER -